← Back to Search

Peer + Text Message Support for Mental Illness

N/A

Waitlist Available

Led By Vincent Agyapong, MD,PhD

Research Sponsored by University of Alberta

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patients who are 18 or 65 years of age

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 24 weeks, 52 weeks

Awards & highlights

No Placebo-Only Group

Summary

This trial will test whether sending supportive text messages to patients' mobile phones can reduce psychiatric readmissions and emergency department visits.

Who is the study for?

This trial is for adults aged 18 to 65 who are being discharged from acute psychiatric care, have a mental health diagnosis, can consent to participate, and own a mobile device that can receive texts. It's not for those with addiction disorders without a mental health diagnosis or who cannot read texts.

What is being tested?

The study tests whether daily supportive text messages based on cognitive behavioral therapy principles and peer support by recovered patients can reduce hospital readmissions among recently discharged psychiatric patients awaiting follow-up treatment.

What are the potential side effects?

There may be no direct medical side effects from participating in this trial as it involves receiving text messages and peer support rather than medication. However, participants might experience emotional discomfort or distress.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 18 and 65 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 24 weeks, 52 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 24 weeks, 52 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 24 weeks, 52 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change in 30 day readmission rate

Secondary study objectives

Change in Brief Resilience Scale scores

Change in Clinical Outcomes in Routine Evaluation 10 (CORE-10) scores

Change in EuroQol- 5 Dimension (EQ-5D)scores

+2 more

Other study objectives

Acceptability of the intervention

Change in the Reach of the Text4Support

Change in the fidelity of the intervention

+1 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups

Experimental Treatment

Active Control

Group I: Text message with or without peer supportExperimental Treatment2 Interventions

All individuals in this cluster will receive daily text message support for six months plus weekly text message over 6 weeks (six information text messages all together) with some selected members also receiving peer support for six months

Group II: Text Message clusterExperimental Treatment1 Intervention

This arm will receive only daily text message support for six months plus weekly text message over 6 weeks (six information text messages all together)

Group III: Control groupActive Control1 Intervention

This group will only receive usual care plus weekly text message over 6 weeks (six information text messages all together) with provides information about community services

0 / 1Eligibility criteria met